Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hookipa Pharma Inc (HOOK)

Hookipa Pharma Inc (HOOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,765
  • Shares Outstanding, K 12,189
  • Annual Sales, $ 43,950 K
  • Annual Income, $ -43,500 K
  • EBIT $ -52 M
  • EBITDA $ -49 M
  • 60-Month Beta 0.91
  • Price/Sales 0.25
  • Price/Cash Flow N/A
  • Price/Book 0.37
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.50
  • Most Recent Earnings $0.09 on 11/14/25
  • Next Earnings Date 02/26/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 26.43%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Expected Move (DTE 16) 1.4450 (165.14%)
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A
  • Expected Range 0.0000 to 2.3200

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.10
  • Growth Rate Est. (year over year) +90,918.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8350 +4.79%
on 12/01/25
0.9100 -3.85%
on 12/18/25
-0.0160 (-1.80%)
since 11/28/25
3-Month
0.8350 +4.79%
on 12/01/25
0.9400 -6.91%
on 10/31/25
-0.0500 (-5.41%)
since 09/30/25
52-Week
0.7200 +21.53%
on 04/09/25
2.8000 -68.75%
on 01/10/25
-1.1450 (-56.68%)
since 12/30/24

Most Recent Stories

More News
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program...

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for...

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers

HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Reports Second Quarter 2022 Financial Results and Corporate Updates

HB-200 Phase 1 data presented at ASCO met all endpoints in heavily pre-treated head and neck cancer patients; Phase 2 study underwayUS Food and Drug...

HOOK : 0.8750 (-0.93%)

Business Summary

HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in...

See More

Key Turning Points

3rd Resistance Point 0.8958
2nd Resistance Point 0.8917
1st Resistance Point 0.8833
Last Price 0.8750
1st Support Level 0.8708
2nd Support Level 0.8667
3rd Support Level 0.8583

See More

52-Week High 2.8000
Fibonacci 61.8% 2.0054
Fibonacci 50% 1.7600
Fibonacci 38.2% 1.5146
Last Price 0.8750
52-Week Low 0.7200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar